Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, October 28 at 2:00 PM ET

Register Free →

This Government Contract opportunity from Department Of Defense was posted on March 26, 2025. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Notice of Intent to Sole Source supply of blood additive solution for use in Naval Hospital Guam-Agana (NHGA)

Awarded
HT941025P0077Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 621991
New
Federal
Human Cadaver - Based Medical Training and Program Support Services for the 44th Medical Brigade stationed at Fort Bragg Army Base, North Carolina.
Solicitation # 0012468284
The Medical Acquisition Support Office – Alpha is seeking capable vendors to provide human cadaver-based medical training and program support for the 44th Medical Brigade. The scope of work includes the procurement and delivery of up to 20 ethically sourced, non-dissected perfused whole-body cadaver specimens annually, which must be serologically negative for HIV, Hepatitis B/C, and Syphilis. The contractor is responsible for providing refrigerated transportation to primary performance sites at Fort Bragg, NC; Fort Campbell, KY; Fort Stewart-Hunter Army Airfield, GA; and Fort Polk, LA. Additionally, the contractor must provide rental medical equipment and consumable Class VIII supplies, such as surgical packs, tourniquets, and simulated blood. The requirement includes providing highly qualified Subject Matter Experts (SMEs) to support up to 10 training events per fiscal year. These SMEs must be board-certified general surgeons with specific competencies in various trauma procedures, such as cricothyroidotomy and exploratory laparotomy, to serve as instructors and mentors. The anticipated contract structure consists of a base period followed by four one-year option periods. All personnel must comply with strict Installation Access Control System requirements, including Anti-Terrorism Level I and iWatch training, to gain access to military installations.
W40M MRC0 West

POSTED

2 days ago

DEADLINE

in 10 days
NAICS: 621991
New
Federal
6505--Human Blood and Blood Products
Solicitation # 36C25727Q0049
The Department of Veterans Affairs, Network Contracting Office 17, intends to award a single-award, firm-fixed-price Indefinite Delivery/Indefinite Quantity (IDIQ) contract to the South Texas Blood and Tissue Center. This procurement is for the supply and delivery of human blood and blood products, as well as guidance in clinical pathology procedures, to support the Audie L. Murphy Veterans Health Care Center within the South Texas Veterans Health Care System in San Antonio, Texas. The government is pursuing this as a sole source procurement under the authority of 41 U.S.C. 3304(a)(1) and FAR 6.103-1, asserting that only one responsible source can satisfy the agency's requirements. The contractor must maintain AABB and College of American Pathologists (CAP) accreditation and hold an unrevoked U.S. license from the FDA Bureau of Biologics. Key operational requirements include 24/7/365 availability and a tiered delivery system: STAT orders must be delivered within 60 minutes, ASAP orders within 2 hours, and routine orders within 24 hours. All products must be collected via closed systems under aseptic conditions, labeled according to the ABO Blood Group System and Rh type, and transported in compliance with FDA, AABB, and DOT regulations to ensure proper temperature maintenance. Acceptance of deliveries is based on STVHCS Blood Bank criteria, including physical appearance, contamination checks, and specific shelf-life minimums for red blood cells, plasma, and cryoprecipitate.
257-NETWORK Contract Office 17 (36C257)

POSTED

6 days ago

DEADLINE

in 15 days
NAICS: 621991
New
Grant
Limited Competition: Biospecimen Banks to support NCI National Clinical Trials Network Biospecimen Banks (NCTN Biobanks) and the NCI Early-Phase and Experimental Clinical Trials Biospecimen Bank (EET Biobank) (U24 Clinical Trial Not Allowed)
Solicitation # RFA-CA-28-004
The National Cancer Institute (NCI) has issued a Limited Competition Notice of Funding Opportunity (RFA-CA-28-004) to support the continuation of two critical biospecimen banking resources: the National Clinical Trials Network (NCTN) Biobanks and the Early-Phase and Experimental Clinical Trials (EET) Biobank. The primary objective is to maintain these national resources for the collection, processing, storage, and distribution of high-quality, clinically annotated human biospecimens. These resources facilitate translational cancer research, biomarker development, and validation by providing essential specimens from NCI-funded clinical trials. The NCI intends to fund approximately six awards for fiscal year 2027, with a total estimated funding of 19 million dollars and a maximum budget of 3 million dollars in direct costs per year for a requested project period of six years. Applications will be evaluated through the NIH peer-review system based on scientific and technical merit, significance, and the adequacy of the institutional environment. Key requirements for applicants include maintaining active registrations in SAM, eRA Commons, and Grants.gov, as well as providing specific documentation regarding the current scale of operations, accomplishments, and standard operating procedures. Awardees must adhere to NCI Best Practices for Biospecimen Resources, federal human subjects regulations under 45 CFR 46, and strict cybersecurity incident reporting protocols, including notification of incidents within 48 hours of discovery. The scope of work includes managing secure informatics systems, providing specimen collection kits, and ensuring the availability of annotated biospecimens for authorized investigators.
National Institutes Of Health

POSTED

6 days ago

DEADLINE

in 4 months
NAICS: 621991
New
Grant
Limited Competition: Biospecimen Banks to support NCI National Clinical Trials Network Biospecimen Banks (NCTN Biobanks) and the NCI Early-Phase and Experimental Clinical Trials Biospecimen Bank (EET Biobank) (U24 Clinical Trial Not Allowed)
Solicitation # RFA-CA-28-004
The National Cancer Institute is issuing a limited competition Notice of Funding Opportunity, solicitation RFA-CA-28-004, to support the continuation of two critical biospecimen banking resources. These resources include the National Clinical Trials Network Biobanks, which support the NCTN and the Community Oncology Research Program, and the Early-Phase and Experimental Clinical Trials Biospecimen Bank, which supports the ETCTN and other early-phase experimental trials. The primary objective is to maintain national infrastructure for the collection, processing, storage, and distribution of high-quality, clinically annotated human biospecimens to enable translational cancer research, biomarker development, and the study of drug response and resistance. Eligible organizations must submit applications by February 12, 2027, to be considered for funding. All submissions will undergo a standard NIH peer-review process, and only meritorious applications will be selected. These banks are essential for linking biospecimens to clinical outcome data from large multi-site trials and supporting the development of novel cancer therapies through pharmacokinetic and pharmacodynamic analyses.
National Cancer Institute

POSTED

6 days ago

DEADLINE

in 4 months
NAICS: 621991
SLED
Mobile Health Unit OperationsThe contract titled Mobile Health Unit Operations seeks a subcontractor to manage the operation and maintenance of mobile units tasked with delivering vision, dental, and hearing services to underserved communities across the region. These mobile units will serve as critical access points for essential health care, ensuring that populations with limited transportation or geographic barriers receive timely and consistent medical attention. The work involves the full lifecycle management of the units, including routine maintenance, repairs, staffing coordination, logistics, and compliance with health and safety standards to guarantee reliable service delivery. The contract is categorized as a subcontract under NAICS code 621991 and is solicited by the Houston-Galveston Area Council through the Texas SmartBuy platform. The solicitation was posted on July 22, 2026, with a response deadline of July 29, 2027, providing over a year for prospective vendors to prepare proposals. The place of performance spans the region served by the council, though exact locations are not specified, indicating flexibility in service deployment based on community need. While details on set-aside status and point of contact are unavailable, the focus remains on operational excellence and equitable access to preventive and diagnostic health services in areas lacking permanent clinical infrastructure.
HOUSTON-GALVESTON AREA COUNCIL

POSTED

3 months ago

DEADLINE

in 9 months

AI Contract Overview

Show more

This firm-fixed-price, sole source supply contract was awarded to Haemonetics Corporation by the Defense Health Agency for the procurement of blood additive solutions for use at Naval Hospital Guam-Agana. The acquisition specifically covers Haemonetics 250mL Anticoagulant Citrate Phosphate Double Dextrose and Additive Solution Formula 3, with an estimated total value of 23,519.25 dollars. The procurement was conducted under FAR Subpart 13.5 and 14 U.S.C. 1901 Simplified Acquisition Procedures following a Notice of Intent to Sole Source, as Haemonetics Corporation is identified as the only manufacturer capable of providing products compatible with the facility's existing equipment. The contract, identified by solicitation number HT941025P0077 and NAICS code 621991, requires delivery of the supplies by June 30, 2025. Performance will take place in Agana Heights, Guam. The action was managed by the Defense Health Agency Hcd West, based in Camp Pendleton, California, and was finalized after no additional information was received from other interested parties.

General Info

Contract Value

$23,519.25

NAICS

621991 - Blood and Organ Banks

Place of Performance

Agana Heights, GU, 96910, USA

Set-Aside

NONE

Award Issued Date

Documents

1

JNCP - Haemonetics Blood Additives for Naval Hospital Guam

PDF, Low priorityjustification-and-authorization
Low

AI Contract Breakdown

Uniform Contract Format

Contract not broken down yet

CLEATUS splits the solicitation into Uniform Contract Format (UCF) sections: scope, pricing, deliverables, and evaluation criteria.

Timeline

PhaseAwarded
Posted

Award Notice

Awarded

Contract was awarded

Submission Closed

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → Defense Health Agency Hcd West
Contacts2 people available
OfficeCAMP PENDLETON, CA, 92055, USA
Office AddressCAMP PENDLETON, CA, 92055, USA

Full Description

Show more
This requirement for blood additive solution for use at Naval Hospital Guam-Agana was awarded as a firm-fixed-price, sole source, supply contract to Haemonetics Corporation pursuant to FAR Subpart 13.5 and in accordance with 14 U.S.C. 1901 Simplified Acquisition Procedures after receiving no additional information from interested parties in response to Notice of Intent to Sole Source HT941025N0048.

More opportunities from Department Of Defense → Defense Health Agency Hcd West

Same awarding agency

NAICS: 532490
New
Federal
Notice of Intent to Sole Source - Arthrex Lease NHCP
Solicitation # HT941027N0006
The Defense Health Agency Contracting Activity intends to award a firm fixed price sole source purchase order contract to Arthrex Inc for an equipment placement agreement at Naval Hospital Camp Pendleton. This requirement, identified under solicitation HT941027N0006, involves the placement, delivery, and support of specific Arthrex surgical equipment, including models AR-6480, AR-8305, AR-9800-F, AR-9800, AR-8310, and AR8332H. Under this agreement, Arthrex Inc retains title to the equipment and is responsible for all preventative maintenance, corrective repairs, and software updates according to original equipment manufacturer specifications to ensure operational readiness for patient care. The contract is classified under NAICS code 532490 for other commercial and industrial machinery and equipment rental and leasing, with a product service code of W065. The base period of performance is scheduled from November 18, 2026, to November 17, 2027, with additional provisions for four option years. All equipment must undergo safety inspections by NHCP Medical Repair in accordance with hospital policy prior to clinical use. As a sole source acquisition under FAR 6.302-1 and FAR 12.102(a), the government has determined that Arthrex Inc is the only source capable of meeting these specific needs. Interested parties wishing to challenge this intent must submit a capability statement to the designated point of contact by October 21, 2026.
Other Commercial and Industrial Machinery and Equipment Rental and Leasing

POSTED

5 days ago

DEADLINE

in about 17 hours
View Details
NAICS: 621511
Federal
BPA for Medical Laboratory Testing Services at 18th Medical Group - Kadena Air Base, Japan
Solicitation # HT941026Q2050
Solicitation HT941026Q2050 is a Request for Quote for a five-year Blanket Purchase Agreement to provide medical reference laboratory testing services for the 18th Medical Group at Kadena Air Base, Japan. The period of performance is scheduled from December 1, 2026, to November 30, 2031. The contractor is responsible for providing all management, labor, equipment, and supplies necessary to perform specific tests, including fungal cultures and identification, TSPOT-TB testing, and antifungal drug susceptibility tests. A critical requirement is that the contractor must maintain current accreditation with the College of American Pathologists, and all reported results must be delivered in English. The procurement is a Total Small Business Set-Aside under NAICS code 621511. Award decisions will be based on a Past Performance Price Tradeoff, where past performance is explicitly weighted as more important than price. Technical capability will be evaluated on an acceptable or unacceptable basis. Offerors must submit a capabilities statement not exceeding two pages and provide past performance questionnaires for up to two relevant projects from the last three years. Invoicing is managed through Wide Area WorkFlow, and contractors must comply with various FAR and DFARS regulations, including those regarding cybersecurity, antiterrorism training, and medical liability insurance.
Medical Laboratories

POSTED

about 1 month ago

DEADLINE

in 5 days
View Details
NAICS: 621111
Federal
OCONUS Medical Q-Coded Services
Solicitation # HT941026R2000
Solicitation HT9410-26-R-2000 is a competitive 8(a) small business set-aside Request for Proposal issued by the Defense Health Agency Healthcare Contracting Division-West. The government intends to award five single-award Indefinite Delivery Indefinite Quantity (IDIQ) contracts to provide OCONUS medical Q-coded services in support of military treatment facilities, specifically within the Indo-Pacific Command regions of Japan and Korea. The scope of work covers five distinct labor segments: direct patient service providers, mental health, nursing services, medical support, and dental services. The resulting contracts will be firm-fixed-price with a five-year ordering period, requiring the contractor to recruit, qualify, and manage both credentialed and non-credentialed healthcare workers. Award decisions will be based on a best-value tradeoff process, prioritizing technical capability and past performance over price. Technical capability is the most important non-price factor, while the small business participation plan is a pass/fail requirement. Offerors must demonstrate quality management capabilities through ISO 9001 or Joint Commission Health Care Staffing Services certification. Key submission requirements include detailed disclosures of corporate relationships in the cover letter and strict adherence to the required period of acceptance to avoid being deemed non-compliant. Personnel must meet minimum qualifications defined in the contract exhibits and comply with DHA credentialing and privileging standards, as well as Status of Forces Agreement requirements for performance in Japan and Korea.
Offices of Physicians (except Mental Health Specialists)

POSTED

about 2 months ago

DEADLINE

in 6 months
View Details

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS